Gout
📧 Sign up to get email alerts when something new happens for Gout.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-06-27Clinical Trial Update: The Effect of Tart Cherry Juice on Risk of Gout Attacks [NA]
A clinical trial evaluating the effect of tart cherry juice on the risk of gout attacks was terminated.
-
CLINICAL_TRIALS trial_result · 2024-06-03Clinical Trial Update: Relation Between Blood Concentration of Colchicine and Response to Colchicine Treatment in Gout Flare [Phase 4]
Phase 4 trial evaluating the relationship between colchicine blood concentration and response in gout flare; the study was terminated.
-
CLINICAL_TRIALS trial_result · 2024-05-24Clinical Trial Update: A Nurse Led Patient Management Programme to Improve Outcomes in Gout [NA]
Completed clinical trial evaluating a nurse-led patient management program to improve outcomes in gout and related arthritis.
-
CLINICAL_TRIALS trial_result · 2024-05-21Clinical Trial Update: Gout Self-Monitoring Aiming to Reach Target [NA]
A completed clinical trial on self-monitoring for gout has posted results as of 2024-05-21. The study was conducted at the University of Edi…
-
CLINICAL_TRIALS trial_result · 2023-12-14Clinical Trial Update: A Study of Recombinant Anti-IL-1β Humanized Monoclonal Antibody Injection in Chinese Participants With Acute Gout [Phase 3]
Phase 3 clinical trial update of a recombinant anti-IL-1β monoclonal antibody for acute gout in Chinese participants.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-12-14Clinical Trial Update: Orlistat Reduces Uric Acid in Overweight/Obese Patients With Hyperuricemia [Phase 4]
Phase 4 trial reporting that orlistat reduces uric acid in overweight/obese patients with hyperuricemia.
-
CLINICAL_TRIALS trial_result · 2023-10-27Clinical Trial Update: Pilot Study Evaluating The Efficacy Of Etanercept In Acute Gout [Phase 4]
Pilot Phase 4 trial evaluating etanercept for acute gout has been terminated; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-10-17Clinical Trial Update: A Study to Compare the Efficacy of SEL-212 to KRYSTEXXA® in Gout Participants Refractory to Conventional Therapy [Phase 2]
Phase 2 trial comparing SEL-212 to KRYSTEXXA in patients with chronic gout refractory to conventional therapy has been completed with result…
-
CLINICAL_TRIALS trial_result · 2023-10-10Clinical Trial Update: Pegloticase and Methotrexate Co-administered in Participants With Uncontrolled Gout Who Previously Failed Pegloticase Monotherapy [Phase 4]
Phase 4 study evaluating co-administration of pegloticase with methotrexate in patients with uncontrolled gout who previously failed pegloti…
-
CLINICAL_TRIALS trial_result · 2023-06-22Clinical Trial Update: An Inpatient Study of ALLN-346 (Engineered Urate Oxidase) in Hyperuricemic Subjects (Study 201) [Phase 2]
Phase 2 trial update of ALLN-346 (engineered urate oxidase) in hyperuricemic subjects has completed enrollment and status.
-
CLINICAL_TRIALS trial_result · 2023-05-12Clinical Trial Update: Phase 2b Evaluation of Efficacy and Safety of AR882 in Gout Patients [Phase 2]
Phase 2b trial evaluating AR882 for gout shows completed status; provides data on efficacy and safety in gout patients.
-
CLINICAL_TRIALS trial_result · 2023-05-09Clinical Trial Update: Rasburicase Treatment in Chronic Gouty Arthritis [Phase 4]
Phase 4 clinical trial update evaluating rasburicase treatment for chronic gout.
-
CLINICAL_TRIALS trial_result · 2023-04-12Clinical Trial Update: A Study to Assess the Efficacy, Safety, and Pharmacokinetics of ABP-671 in Patients With Gout or Hyperuricemia [Phase 2]
Phase 2 trial evaluating ABP-671 for efficacy, safety, and pharmacokinetics in gout and hyperuricemia has completed.
-
CLINICAL_TRIALS trial_result · 2023-01-04Clinical Trial Update: An Innovative Chinese Herbal Formula for the Treatment of Gout [Phase 2]
Phase 2 clinical trial update for an innovative Chinese herbal formula targeting gout.
-
CLINICAL_TRIALS trial_result · 2022-10-20Clinical Trial Update: A Phase Ib/II Study of Recombinant Anti-IL-1β Humanized Monoclonal Antibody Injection in Chinese Participants With Acute Gout [Phase 1, Phase 2]
A Phase Ib/II clinical trial evaluating a recombinant anti-IL-1β monoclonal antibody in Chinese participants with acute gout is in early-pha…
-
CLINICAL_TRIALS trial_result · 2022-08-24Clinical Trial Update: Clinical Study of SHR4640 Tablets Combined With Febuxostat Tablets in the Treatment of Primary Gout and Hyperuricemia [Phase 2]
Phase 2 clinical trial evaluating SHR4640 tablets in combination with febuxostat for primary gout and hyperuricemia.
-
CLINICAL_TRIALS trial_result · 2022-08-24Clinical Trial Update: The Impact of Urate-lowering Therapy on Kidney Function (IMPULsKF) [Phase 4]
A phase 4 clinical trial assessing the impact of urate-lowering therapy on kidney function in patients with gout and chronic kidney disease …
-
CLINICAL_TRIALS trial_result · 2022-08-01Clinical Trial Update: Pharmacogenetics of SGLT2 Inhibitors [Phase 4]
Phase 4 trial update on pharmacogenetics of SGLT2 inhibitors; terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2022-07-26Clinical Trial Update: Study of Pegloticase in Participants With Uncontrolled Gout Who Have Had a Kidney Transplant [Phase 4]
This Phase 4 trial evaluated pegloticase in adults with uncontrolled gout who have had a kidney transplant; results were posted in July 2022…
-
CLINICAL_TRIALS trial_result · 2022-07-25Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Evaluation of RPH-104 Administered at Different Doses to Patients With Acute Gout Attack [Phase 2]
Phase 2 clinical trial evaluating safety, tolerability, pharmacokinetics and pharmacodynamics of RPH-104 at different doses in patients with…
-
CLINICAL_TRIALS trial_result · 2022-06-13Clinical Trial Update: A Study of Evaluating the Efficacy and Safety of SHR4640 in Subjects With Gout [Phase 3]
Phase 3 trial evaluating the efficacy and safety of SHR4640 in subjects with gout has completed.
-
CLINICAL_TRIALS trial_result · 2022-05-16Clinical Trial Update: Study of KRYSTEXXA® (Pegloticase) Plus Methotrexate in Participants With Uncontrolled Gout [Phase 4]
Phase 4 trial evaluating KRYSTEXXA (pegloticase) plus methotrexate in uncontrolled gout has been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-05-13Clinical Trial Update: Topical Application to Relieve Gout: Efficacy Trial & Safety (TARGETS) [Phase 2]
Phase 2 trial update evaluating topical treatment for gout, reporting efficacy and safety outcomes.
-
CLINICAL_TRIALS trial_result · 2022-05-06Clinical Trial Update: D-0120 Safety and PK/PD Study in China [Phase 1, Phase 2]
Phase 1/2 safety and PK/PD trial of D-0120 completed in China for hyperuricemia or gout.
-
CLINICAL_TRIALS trial_result · 2022-04-06Clinical Trial Update: Anakinra vs. Steroids for the Treatment of Gout Attacks in Patients With Renal Disease (ASGARD): A Feasibility Study [Phase 2, Phase 3]
A feasibility study comparing anakinra versus steroids for treating gout attacks in patients with renal disease (ASGARD) completed.